logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 5
  • 1
    Driscoll, Cindy
    Svp Finance born in May 1965
    Individual (1 offspring)
    Officer
    icon of calendar 2025-06-26 ~ now
    OF - Director → CIF 0
  • 2
    Brennan, Aoife
    Ceo born in June 1975
    Individual (1 offspring)
    Officer
    icon of calendar 2024-08-08 ~ now
    OF - Director → CIF 0
  • 3
    Adams, Chandra
    Attorney born in June 1978
    Individual (1 offspring)
    Officer
    icon of calendar 2025-06-26 ~ now
    OF - Director → CIF 0
  • 4
    icon of addressCorporation Service Company, 251 Little Falls Drive, Wilmington, Delaware, United States
    Corporate (1 offspring)
    Person with significant control
    icon of calendar 2021-08-21 ~ now
    PE - Ownership of shares – 75% or more → CIF 0
    PE - Ownership of voting rights - 75% or more → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 5
    icon of address3rd Floor, 1 Ashley Road, Altrincham, Cheshire, United Kingdom
    Active Corporate (7 parents, 2633 offsprings)
    Total Assets Less Current Liabilities (Company account)
    1 GBP2016-09-30
    Officer
    icon of calendar 2019-12-05 ~ now
    OF - Secretary → CIF 0
Ceased 6
  • 1
    Palmer-phillips, Joanne Eryl, Dr
    Chief Development Officer born in June 1973
    Individual (2 offsprings)
    Officer
    icon of calendar 2021-10-08 ~ 2024-08-13
    OF - Director → CIF 0
  • 2
    Gaby, Helen Louise
    Senior Director Operations Uk born in March 1968
    Individual
    Officer
    icon of calendar 2021-10-08 ~ 2024-08-15
    OF - Director → CIF 0
  • 3
    Pimblett, Emily
    Chief Accounting Officer born in April 1983
    Individual
    Officer
    icon of calendar 2024-08-08 ~ 2025-06-26
    OF - Director → CIF 0
  • 4
    Morisset, Valerie Daniele
    Executive Vp R&D And Chief Scientific Officer born in October 1969
    Individual
    Officer
    icon of calendar 2019-12-18 ~ 2024-08-23
    OF - Director → CIF 0
    Mrs Valerie Daniele Morisset
    Born in October 1969
    Individual
    Person with significant control
    icon of calendar 2019-12-18 ~ 2021-10-01
    PE - Right to appoint or remove directors → CIF 0
  • 5
    Levin, Andrew David
    Investor born in November 1976
    Individual (1 offspring)
    Officer
    icon of calendar 2019-03-20 ~ 2019-12-18
    OF - Director → CIF 0
    Andrew David Levin
    Born in November 1976
    Individual (1 offspring)
    Person with significant control
    icon of calendar 2019-03-20 ~ 2019-12-18
    PE - Right to appoint or remove directors → CIF 0
  • 6
    BROWN RUDNICK FREED & GESMER LLP - 2002-02-12
    BROWN RUDNICK BERLACK ISRAELS LLP - 2008-04-29
    icon of address8, Clifford Street, London, United Kingdom
    Active Corporate (25 parents, 1 offspring)
    Profit/Loss (Company account)
    4,324,082 GBP2023-01-01 ~ 2023-12-31
    Officer
    2019-03-20 ~ 2019-05-15
    PE - Secretary → CIF 0
parent relation
Company in focus

ELIEM THERAPEUTICS (UK) LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
62024-01-01 ~ 2024-12-31
212023-01-01 ~ 2023-12-31
Intangible Assets
7,373,319 GBP2023-12-31
Debtors
Current
111,766 GBP2024-12-31
2,195,893 GBP2023-12-31
Cash at bank and in hand
49,544 GBP2024-12-31
3,508,583 GBP2023-12-31
Current Assets
161,310 GBP2024-12-31
5,704,476 GBP2023-12-31
Net Current Assets/Liabilities
80,168 GBP2024-12-31
3,783,649 GBP2023-12-31
Total Assets Less Current Liabilities
80,168 GBP2024-12-31
11,156,968 GBP2023-12-31
Net Assets/Liabilities
80,168 GBP2024-12-31
11,156,968 GBP2023-12-31
Equity
Called up share capital
913 GBP2024-12-31
788 GBP2023-12-31
661 GBP2023-01-01
Share premium
113,328,835 GBP2024-12-31
110,299,293 GBP2023-12-31
107,064,005 GBP2023-01-01
Other miscellaneous reserve
1,118,647 GBP2024-12-31
2,167,152 GBP2023-12-31
2,854,392 GBP2023-01-01
Retained earnings (accumulated losses)
-114,368,227 GBP2024-12-31
-101,310,265 GBP2023-12-31
-84,139,188 GBP2023-01-01
Equity
80,168 GBP2024-12-31
11,156,968 GBP2023-12-31
25,779,870 GBP2023-01-01
Profit/Loss
Retained earnings (accumulated losses)
-13,057,962 GBP2024-01-01 ~ 2024-12-31
-17,171,077 GBP2023-01-01 ~ 2023-12-31
Profit/Loss
-13,057,962 GBP2024-01-01 ~ 2024-12-31
-17,171,077 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
Retained earnings (accumulated losses)
-13,057,962 GBP2024-01-01 ~ 2024-12-31
-17,171,077 GBP2023-01-01 ~ 2023-12-31
Comprehensive Income/Expense
-13,057,962 GBP2024-01-01 ~ 2024-12-31
-17,171,077 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
Called up share capital
125 GBP2024-01-01 ~ 2024-12-31
127 GBP2023-01-01 ~ 2023-12-31
Issue of Equity Instruments
3,029,667 GBP2024-01-01 ~ 2024-12-31
3,235,415 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
Called up share capital
125 GBP2024-01-01 ~ 2024-12-31
127 GBP2023-01-01 ~ 2023-12-31
Equity - Income/Expense Recognised Directly
1,981,162 GBP2024-01-01 ~ 2024-12-31
2,548,175 GBP2023-01-01 ~ 2023-12-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
16,287,474 GBP2024-12-31
16,287,474 GBP2023-12-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
16,287,474 GBP2024-12-31
8,914,155 GBP2023-12-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
7,373,319 GBP2023-12-31
Other Debtors
Current
43,077 GBP2024-12-31
Prepayments/Accrued Income
Current
68,689 GBP2024-12-31
202,895 GBP2023-12-31
Amount of corporation tax that is recoverable
Current
1,992,998 GBP2023-12-31
Trade Creditors/Trade Payables
Current
21,900 GBP2024-12-31
37,029 GBP2023-12-31
Amounts owed to group undertakings
Current
12,012 GBP2023-12-31
Taxation/Social Security Payable
Current
414,687 GBP2023-12-31
Other Creditors
Current
692,385 GBP2023-12-31
Accrued Liabilities/Deferred Income
Current
59,242 GBP2024-12-31
764,714 GBP2023-12-31
Creditors
Current
81,142 GBP2024-12-31
1,920,827 GBP2023-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
700 shares2024-12-31
600 shares2023-12-31
Par Value of Share
Class 1 ordinary share
1.002024-01-01 ~ 2024-12-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
171,125 GBP2023-12-31
  • ELIEM THERAPEUTICS (UK) LTD
    Info
    Registered number 11893311
    icon of address3rd Floor 1 Ashley Road, Altrincham, Cheshire WA14 2DT
    Private Limited Company incorporated on 2019-03-20 (6 years 8 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-19
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022-2025 Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 16 October 2025 and licensed under the Open Government Licence v3.0.